Based on the Open Innovation system,
HLB is growing into a global anti-cancer company based on various anti-cancer drugs obtained through a global network.
Under the medium-term vision of 'the Beginning of the Great Goal', we aim to market more than 5 anti-cancer drugs by 2025,
by developing 'Rivoceranib', the best-in-class targeted anti-cancer therapy, and 'UNITE',
the next-generation immunotherapy vaccine platform for cancer and allergies.
We will realize the dream of better life and life extension of humanity.
Founded in 1975, HLB's corporate history is said to b e an abbreviation of Korea's manufacturing history.
A small lifeboat manufacturer on a remote beach in Ulsan made ships and fiberglass pipes, and exported
them to the world. Now, as a result of efforts for over 10 years, we are planning to become
a global pharmaceutical bio company.
We grew up but didn't settle down, and when we fell, we got over and got one step further.
Over the last 40 years, gestures of challenge and passion have been engraved in our hearts
as an entrepreneurship called 'DNA of Overcoming and Breakthrough.'
Using practical corporate ethics and strong entrepreneurship as a weapon, we compete against our own limits.
And the challenge of making our dreams into reality is always making our hearts beat.
As we head toward the 50th anniversary of our foundation,
Will you be our partner in this exciting journey?